A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function

Clinical trial NCT04476849 · COMPLETED

Trial details

NCT number: NCT04476849
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Renal Impairment

Start date: 2020-08-10
Primary completion: 2022-03-06
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.